Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults

D. F. Jansen, W. Timens, D. S. Postma, J. Kraan, J. P. Schouten (Groningen, The Netherlands; Boston, United States Of America)

Source: Annual Congress 2003 - Risk factors for asthma
Session: Risk factors for asthma
Session type: Oral Presentation
Number: 248
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. F. Jansen, W. Timens, D. S. Postma, J. Kraan, J. P. Schouten (Groningen, The Netherlands; Boston, United States Of America). Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults. Eur Respir J 2003; 22: Suppl. 45, 248

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


The influence of FVC manoeuvres on consecutive FEV1 values during methacholine challenge
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Can the interrupter resistance be used to measure airway hyperresponsiveness during the methacholine challenge test as a substitute for FEV1?
Source: Virtual Congress 2021 – New insights into lung function testing
Year: 2021


Comparison of FEV1 and PEF values in cough variant asthma during methacholine challenge test
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020

Comparison of bronchodilatator response of FEV1 and airway resistance
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


A comparison of the response to inhaled histamine measured with FEV1 and sGaw in healthy subjects
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


How often FEV1 underestimates bronchodilator response?
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003

Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 338s
Year: 2004

FEV1 decline in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

FEV1 decline and eosinophilia in occupational asthma
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011


Relationship between FEV1 and PEF in patients with airways obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004

Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


FEV1 and respiratory resistance response to methacholine in children calculated from between-measurement variability
Source: Eur Respir J 2005; 26: Suppl. 49, 43s
Year: 2005

Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids
Source: Annual Congress 2006 - New features of paediatric asthma
Year: 2006


How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009



Exercise-induced bronchoconstriction and bronchodilation: investigating the effects of age, sex, airflow limitation and FEV1
Source: Eur Respir J, 58 (2) 2004026; 10.1183/13993003.04026-2020
Year: 2021



Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio
Source: Eur Respir J 2007; 30: Suppl. 51, 744s
Year: 2007